{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:16:43Z","timestamp":1760242603493,"version":"build-2065373602"},"reference-count":20,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of University and Research","award":["PON03PE_00060_2 (Campania - Bioscience)","PON03PE_00060_7 (Campania - Bioscience)"],"award-info":[{"award-number":["PON03PE_00060_2 (Campania - Bioscience)","PON03PE_00060_7 (Campania - Bioscience)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The aim of this study was to verify the reliability of a next generation sequencing (NGS)-based method as a strategy to detect all possible BRCA mutations, including large genomic rearrangements. Genomic DNA was obtained from a peripheral blood sample provided by a patient from Southern Italy with early onset breast cancer and a family history of diverse cancers. BRCA molecular analysis was performed by NGS, and sequence data were analyzed using two software packages. Comparative genomic hybridization (CGH) array was used as confirmatory method. A novel large duplication, involving exons 4\u201326, of BRCA2 was directly detected in the patient by NGS workflow including quantitative analysis of copy number variants. The duplication observed was also found by CGH array, thus confirming its extent. Large genomic rearrangements can affect the BRCA1\/2 genes, and thus contribute to germline predisposition to familial breast and ovarian cancers. The frequency of these mutations could be underestimated because of technical limitations of several routinely used molecular analysis, while their evaluation should be included also in these molecular testing. The NGS-based strategy described herein is an effective procedure to screen for all kinds of BRCA mutations.<\/jats:p>","DOI":"10.3390\/ijms18112487","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T10:47:38Z","timestamp":1511347658000},"page":"2487","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Fast Detection of a BRCA2 Large Genomic Duplication by Next Generation Sequencing as a Single Procedure: A Case Report"],"prefix":"10.3390","volume":"18","author":[{"given":"Marcella","family":"Nunziato","sequence":"first","affiliation":[{"name":"CEINGE-Biotecnologie Avanzate, via Gaetano Salvatore 486, 80145 Naples, Italy"},{"name":"Department of Movement Sciences and Wellness (DiSMEB), University of Naples Parthenope, via Medina 40, 80133 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"Starnone","sequence":"additional","affiliation":[{"name":"CEINGE-Biotecnologie Avanzate, via Gaetano Salvatore 486, 80145 Naples, Italy"},{"name":"Department of Molecular Medicine and Medical Biotechnologies, University of Naples \u201cFederico II\u201d, via Sergio Pansini 5, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3884-1043","authenticated-orcid":false,"given":"Barbara","family":"Lombardo","sequence":"additional","affiliation":[{"name":"CEINGE-Biotecnologie Avanzate, via Gaetano Salvatore 486, 80145 Naples, Italy"},{"name":"Department of Molecular Medicine and Medical Biotechnologies, University of Naples \u201cFederico II\u201d, via Sergio Pansini 5, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Pensabene","sequence":"additional","affiliation":[{"name":"Oncology Division, Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Condello","sequence":"additional","affiliation":[{"name":"Oncology Division, Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Verdesca","sequence":"additional","affiliation":[{"name":"CEINGE-Biotecnologie Avanzate, via Gaetano Salvatore 486, 80145 Naples, Italy"},{"name":"Department of Molecular Medicine and Medical Biotechnologies, University of Naples \u201cFederico II\u201d, via Sergio Pansini 5, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Carlomagno","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabino","family":"De Placido","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Pastore","sequence":"additional","affiliation":[{"name":"CEINGE-Biotecnologie Avanzate, via Gaetano Salvatore 486, 80145 Naples, Italy"},{"name":"Department of Molecular Medicine and Medical Biotechnologies, University of Naples \u201cFederico II\u201d, via Sergio Pansini 5, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2346-3564","authenticated-orcid":false,"given":"Francesco","family":"Salvatore","sequence":"additional","affiliation":[{"name":"CEINGE-Biotecnologie Avanzate, via Gaetano Salvatore 486, 80145 Naples, Italy"},{"name":"Department of Molecular Medicine and Medical Biotechnologies, University of Naples \u201cFederico II\u201d, via Sergio Pansini 5, 80131 Naples, Italy"},{"name":"IRCCS-Fondazione SDN, via Emanuele Gianturco 113, 80143 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9273-3698","authenticated-orcid":false,"given":"Valeria","family":"D\u2019Argenio","sequence":"additional","affiliation":[{"name":"CEINGE-Biotecnologie Avanzate, via Gaetano Salvatore 486, 80145 Naples, Italy"},{"name":"Department of Molecular Medicine and Medical Biotechnologies, University of Naples \u201cFederico II\u201d, via Sergio Pansini 5, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2017,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrc.2015.21","article-title":"BRCAness revisited","volume":"16","author":"Lord","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000376600","article-title":"Breast cancer risks and risk prediction models","volume":"10","author":"Engel","year":"2015","journal-title":"Breast Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/ejhg.2016.95","article-title":"Finding all BRCA pathogenic mutation carriers: Best practice models","volume":"24","author":"Hoogerbrugge","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1503523","article-title":"The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer","volume":"374","author":"Hartmann","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/aps.2015.89","article-title":"Cancer predisposition genes: Molecular mechanisms and clinical impact on personalized cancer care: Examples of Lynch and HBOC syndromes","volume":"37","author":"Wang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cca.2015.03.045","article-title":"The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches","volume":"446","author":"Esposito","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cancergen.2015.05.031","article-title":"The importance of analysis of long-range rearrangement of BRCA1 and BRCA2 in genetic diagnosis of familial breast cancer","volume":"208","author":"Kwong","year":"2015","journal-title":"Cancer Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-010-0817-z","article-title":"Large genomic rearrangements of the BRCA1 and BRCA2 genes: Review of the literature and report of a novel BRCA1 mutation","volume":"125","author":"Sluiter","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-011-1909-0","article-title":"Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast\/ovarian cancer families: Review of the literature, and reevaluation of the genetic mechanisms involved in their origin","volume":"133","author":"Garre","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1002\/cncr.27556","article-title":"Clinical significance of large rearrangements in BRCA1 and BRCA2","volume":"118","author":"Judkins","year":"2012","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cancergen.2016.11.002","article-title":"Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast\/ovarian cancer families: Implications for genetic testing","volume":"210","author":"Riahi","year":"2017","journal-title":"Cancer Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13053-014-0022-x","article-title":"Identification of a new BRCA2 large genomic deletion associated with high risk male breast cancer","volume":"13","author":"Timoteo","year":"2015","journal-title":"Hered. Cancer Clin. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/161648","article-title":"Cracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and Perspectives","volume":"2015","author":"Precone","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/cncr.28605","article-title":"Should a BRCA2 stop codon human variant, usually considered a polymorphism, be classified as a predisposing mutation?","volume":"120","author":"Esposito","year":"2014","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/ejhg.2016.94","article-title":"New challenges for BRCA testing: A view from the diagnostic laboratory","volume":"24","author":"Wallace","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Esposito, M.V., Nunziato, M., Starnone, F., Telese, A., Calabrese, A., D\u2019Aiuto, G., Pucci, P., D\u2019Aiuto, M., Baralle, F., and D\u2019Argenio, V. (2016). A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17122145"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jmoldx.2017.07.003","article-title":"Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1\/BRCA2: Validation of a One-Step Diagnostic Workflow","volume":"19","author":"Schmidt","year":"2017","journal-title":"J. Mol. Diagn."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/jmedgenet-2011-100133","article-title":"Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: Comprehensive mutational search in a single platform","volume":"48","author":"Lim","year":"2011","journal-title":"J. Med. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Concolino, P., Rizza, R., Hackmann, K., Minucci, A., Scaglione, G.L., De Bonis, M., Costella, A., Zuppi, C., Schrock, E., and Capoluongo, E. (2017). Identification and Characterization of a New BRCA2 Rearrangement in an Italian Family with Hereditary Breast and Ovarian Cancer Syndrome. Mol. Diagn. Ther.","DOI":"10.1007\/s40291-017-0288-6"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.6004\/jnccn.2017.0003","article-title":"NCCN Guidelines Insights: Genetic\/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017","volume":"15","author":"Daly","year":"2017","journal-title":"J. Natl. Compr. Cancer Netw."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/11\/2487\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:50:44Z","timestamp":1760208644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/11\/2487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,22]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11]]}},"alternative-id":["ijms18112487"],"URL":"https:\/\/doi.org\/10.3390\/ijms18112487","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2017,11,22]]}}}